drugset / Trial / NCT02735473
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders
Phase 2
Completed
46 enrolled
University of Minnesota
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled trial of choline supplementation in children with Fetal Alcohol Spectrum Disorders (FASD). The primary outcome measures are cognitive measures.
Timeline
- Start
- 2016-06
- Primary completion
- 2021-09-10
- Completion
- 2021-09-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Choline Bitartrate | Small molecule | 19 mg/kg | — |